Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer

Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer

The underlying molecular mechanisms of resistance to cisplatin-based systemic chemotherapy in bladder cancer patients remain to be elucidated, while the link between androgen receptor (AR) activity and chemosensitivity in urothelial cancer has been implicated. Our DNA microarray analysis in control...

Full description

Bibliographic Details
Main Authors:	Yuki Teramoto, Guiyang Jiang, Takuro Goto, Taichi Mizushima, Yujiro Nagata, George J. Netto, Hiroshi Miyamoto
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	International Journal of Molecular Sciences
Subjects:	androgen receptor chemoresistance cisplatin immunohistochemistry urothelial cancer
Online Access:	https://www.mdpi.com/1422-0067/22/18/10030

Similar Items

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
by: Guiyang Jiang, et al.
Published: (2021-02-01)

GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
by: Mohammad Amin Elahi Najafi, et al.
Published: (2023-09-01)

ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
by: Satoshi Inoue, et al.
Published: (2018-11-01)

Evaluation of androgen receptor status in urothelial carcinoma of the urinary bladder in Egyptian patients: an immunohistochemical study
by: Mohamed Wagih, et al.
Published: (2020-01-01)

Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
by: Lena Berning, et al.
Published: (2021-02-01)

Androgen Receptor Signaling in Bladder Cancer
by: Peng Li, et al.
Published: (2017-02-01)

Androgen receptor in bladder cancer: A promising therapeutic target
by: Abhishek Tripathi, et al.
Published: (2020-07-01)

Cytoplasmic Androgen Receptor, CD24 Expression and Smoking Intensity to Urothelial Carcinoma of the Bladder Invasiveness: A Cross-Sectional Study
by: Pramod SV, et al.
Published: (2023-11-01)

The Role of Androgen Receptor Signaling in Ovarian Cancer
by: Taichi Mizushima, et al.
Published: (2019-02-01)

Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity
by: Lijie Wen, et al.
Published: (2020-04-01)

Pharmacological NF‐κB inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities.
by: Rui M. Gil da Costa, et al.
Published: (2023-12-01)

PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study
by: Fu-Shun Hsu, et al.
Published: (2021-10-01)

Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway
by: Chen Xia, et al.
Published: (2015-09-01)

Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells
by: Miguel Angel Merlos Rodrigo, et al.
Published: (2019-03-01)

Immunohistochemical expression of androgen receptors in urothelial carcinoma of urinary bladder. Is it significant? Experience from coastal India
by: Disha Jindal, et al.
Published: (2023-11-01)

Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells
by: Chien-Hui Weng, et al.
Published: (2020-10-01)

Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma
by: Rongkun Chen, et al.
Published: (2024-04-01)

Cisplatin for cancer therapy and overcoming chemoresistance
by: Ranmali Ranasinghe, et al.
Published: (2022-09-01)

The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer
by: Weilu Wu, et al.
Published: (2023-08-01)

The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin
by: Haochen Su, et al.
Published: (2023-10-01)

Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
by: Wu S, et al.
Published: (2016-10-01)

Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma
by: Kazuma Sugimoto, et al.
Published: (2022-11-01)

Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder
by: Maria V. Luna‐Velez, et al.
Published: (2021-07-01)

LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer
by: Cheng H, et al.
Published: (2021-01-01)

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer
by: Masayuki Hagiwara, et al.
Published: (2018-01-01)

Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
by: M. Kanmalar, et al.
Published: (2022-01-01)

Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways
by: Alejandro Bravo-Cuellar, et al.
Published: (2020-12-01)

FBXW7 Enhances Cisplatin-Induced Apoptosis in Oral Cancer Cell Lines
by: Qi Yang, et al.
Published: (2023-10-01)

Modulation of Cisplatin Sensitivity through TRPML1-Mediated Lysosomal Exocytosis in Ovarian Cancer Cells: A Comprehensive Metabolomic Approach
by: Boyun Kim, et al.
Published: (2024-01-01)

MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway
by: Yang Li, et al.
Published: (2022-02-01)

Modulation of RAB7A Protein Expression Determines Resistance to Cisplatin through Late Endocytic Pathway Impairment and Extracellular Vesicular Secretion
by: Flora Guerra, et al.
Published: (2019-01-01)

Gulp! Electronics Down the Hatch
by: Prachi Patel
Published: (2017-09-01)

Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours
by: Zeeshan Fazal, et al.
Published: (2021-10-01)

A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study
by: Takamitsu Inoue, et al.
Published: (2018-03-01)

Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysis
by: Huitao Wang, et al.
Published: (2019-12-01)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
by: Wenyu Wang, et al.
Published: (2020-11-01)

Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy
by: Amandine Moretton, et al.
Published: (2022-06-01)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
by: Milad Ashrafizadeh, et al.
Published: (2020-06-01)

Androgen Receptor Expression in Triple-negative Breast Cancer and its Relation with Epidermal Growth Factor Receptor, CD 105, and Clinicopathological Parameters
by: Nehal El Badawy, et al.
Published: (2021-07-01)

Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect
by: Julieta Afonso, et al.
Published: (2024-04-01)